A quick search showed this, 27.4 is very low. PTX200 is a possible treatment. Trial is ongoing Phase 1B/2.
"The five-year overall survival rate for AML is 27.4 percent, according to the National Cancer Institute (NCI). This means that of the tens of thousands of Americans living with AML, an estimated 27.4 percent are still living five years after their diagnosis"
Ann: Third complete response in PTX-200 AML Trial, page-33
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.7¢ | 4.6¢ | $3.604K | 77.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 74506 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 216090 | 7 |
View Market Depth
| Last trade - 12.07pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.7¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.6¢ | 35774 | ||
| Last updated 12.41pm 29/05/2024 ? | |||||
| PTX (ASX) Chart |